Author:
Adamsheck Hallee C.,Petty Elizabeth M.,Hong Jinkuk,Baker Mei W.,Brilliant Murray H.,Mailick Marsha R.
Funder
Centers for Disease Control and Prevention
Waisman Center Core Grant
National Human Genome Research Institute (US)
National Center for Advancing Translational Sciences (US)
Reference19 articles.
1. Brown, W. T. (2002). The molecular biology of the fragile X mutation. In R. J. Hagerman & P. J. Hagerman (Eds.), Fragile X syndrome: Diagnosis, treatment and research (3rd ed., pp. 110–135). Baltimore: Johns Hopkins University Press.
2. Cavanagh, H., & Rogers, K. M. A. (2015). The role of BRCA1 and BRCA2 mutations in prostate, pancreatic, and stomach cancers. Hereditary Cancer and Clinical. Practice, 13, 16.
3. Dagan, E., Cohen, Y., Mory, A., Adir, V., Borochowitz, Z., Raanani, H., et al. (2013). BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study. European Journal of Human Genetics, 22, 277–279.
4. Fiederling, J., Shams, A. Z., & Haug, U. (2016). Validity of self-reported family history of cancer: a systematic literature review on selected cancers. International Journal of Cancer, 139, 1449–1460.
5. Gleicher, N., Weghofer, A., & Barad, D. H. (2010). Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing. Reproductive Biomedicine Online, 20, 768–775.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献